Understanding the costs and cost-effectiveness of TB treatment in Bangladesh

Location

Bangladesh, Bangladesh

Dates

01/01/2013 - 07/01/2015

PI

David Dowdy, MD, PhD

We have conducted an empirical costing analysis of facility-based versus community-based treatment for TB in Bangladesh and are using these results to construct models of the cost-effectiveness of novel shorter-course regimens for drug-susceptible TB.

Projects

Understanding the impact of combined TB and...

We are developing models to understand the overlap of TB and HIV in three epidemiologically distinct settings (Canada, India,...

Read More

Modeling the impact of spatially targeted TB...

 We have developed transmission models to understand the impact of TB vaccination strategies that target hotspots of...

Read More

TB Modeling and Analysis Consortium (TB MAC)

Dr. Dowdy serves on the steering committee of an international consortium of TB modelers that aims to improve approaches to TB...

Read More

A Comprehensive Snapshot of Tuberculosis...

This study aims to find all cases of TB within an urban Ugandan community of 50,000 people and to characterize both the...

Read More